Stiftung Charité is providing EUR 900,000 to support Charité’s new Profile Partnerships Program, part of the university hospital’s Internationalization Strategy 2030.
Lucid Genomics’ tertiary pipeline is validated for the interpretation of data generated using Oxford Nanopore sequencing.
Strategic Initiative Strengthens Berlin as Europe’s Hub of Digital Cardiology
Charité study collates global therapeutic experiences for the first time
Groundbreaking discovery of antimicrobial peptides in ant venom has far-reaching implications
In “Nature Communications,” Max Delbrück Center researchers show how immune cells initiate zebrafish heart regeneration, highlighting the possibility that precisely timed inflammatory signaling of specific immune cells — rather than broad…
On April, 22th, the BeCAT and Si-M were inaugurated in Berlin—two important beacons for our region. What they share is the goal of developing effective personalized therapies for diseases that have so far been considered incurable.
16.-20.11.2026 | Anmeldeschluss 30.06.2026
New study presents theoretical framework to address a conceptual gap in our understanding of ADHD
According to a TU Berlin study, ChatGPT models tend to make overly cautious recommendations, and are currently inadequate for the targeted management of patients in healthcare systems
